Bioinformatics pipelines race to outsmart multidrug-resistant tuberculosis
A new review maps how machine learning, molecular docking and subtractive genomics are being combined to explain drug resistance in ...
A new review maps how machine learning, molecular docking and subtractive genomics are being combined to explain drug resistance in ...
A phase 3 trial of the pan-RAS inhibitor daraxonrasib doubled median overall survival in previously treated metastatic pancreatic cancer, prompting ...
Scientists engineered an HVEM-derived peptide that blocked about sixty percent of HSV-1 infection in cell tests without toxicity.
A study of 335 Mycobacterium tuberculosis isolates in China found a pretomanid 99th percentile MIC of 0.25 mg/L in 7H9 ...
A new bibliometric and pharmacological review of 423 Scopus-indexed publications maps four decades of anticancer quinazoline research, revealing a 2018 ...
A new review maps how the four HSP90 chaperone isoforms play distinct roles in lung cancer progression and drug resistance, ...
A new open-access review in Cancer Nanotechnology surveys how nanomaterials could improve colorectal cancer diagnosis, targeted therapy, and personalized theranostics.
A new small molecule strategy activates a stress-responsive E3 ligase to degrade multiple disease-causing proteins at once, restoring mitochondrial function ...
High CD84 expression correlates with venetoclax resistance in AML, and targeting the CD84-SESN2 pathway sensitized leukemia cells to the drug ...
A new review in Cellular Oncology argues that treatment resistance in cancer often stems from selection and remodeling of pre-existing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine